Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.73% to 9584.57, DAX +0.28% to 24219.09, CAC40 +0.33% to 8233.95, STOXX 600 +0.43% to 574.73

Oct 23 ,2025

  • Synopsis:

    • European equity markets ended generally higher with pan-European indices just off session highs. Finland +3.1%, Norway +1.5%, Netherlands +0.8% led the overperformers while Switzerland (0.5%) and Belgium (0.1%) lagged behind.

    • US-China trade situation remains fluid following reports White House readying announcement on software-related exports to China covering an array of products items as laptops and airlines. Some skepticism whether US will implement such an action given likely economic consequence. Trump also talking up prospects of a deal with Xi at their planned APEC meeting this month.

    • Geopolitics driving commodity price action with oil rallying after US Treasury Department announced sanctions on Russia's two largest oil producers, Rosneft and Lukoil, citing Moscow's lack of serious commitment to Ukraine peace process. Emerging fallout extending to India with Bloomberg sources noting flows to Indian refiners expected to grind to a halt. Europe set to move ahead with own sanctions package Thursday, which includes ban on Russian LNG imports. Developments follow on from earlier reports US lifted restrictions on Ukraine's use of European long-range missiles against Russia, but not US Tomahawk missile.

    • From a macroeconomic calendar perspective, French business sentiment improved in October. UK CBI industrials trends survey highlighted entrenched weakness in manufacturing sector. Eurozone flash consumer confidence due for publication in the afternoon session. Overseas, BOK on hold as expected while retaining dovish stance. Elsewhere, Bloomberg reports BoE to move its financial regulator, slimming down its presence in City of London, to save money. Meanwhile, recent fall in UK bond yields tipped to save Reeves ~£4.5B if fiscal watchdog uses current market pricing.

    • In corporate news, Thales (HO.FP) and Orange (ORA.FR) updated the market with their most recent earrings. In the DACH region, Roche Holding (ROG.SW) released Q3 earnings and raised FY outlook. Kuehne & Nagel (KNIN.SW), Lonza Group (LONNSW) and Inficon Holding (IFCN.SW) also reported Q3 earnings/trading updates. From the Benelux, BE Semiconductor Industries (BESI.NA) posted Q3 numbers, Heineken (HEIA.NA) targets mid-single digit revenue growth in EverGreen 2030 and Barco (BAR.BB) reaffirmed FY guidance and sets targets for 2028. Out of the Nordics, Nokia (NOKIA.FH) posted solid results and announced dividend of of €0.03 per share. Essity (ESSITY.B.SS) beat Q3 EPS expectations. Kone (KNEBV.FH), Skandinaviska Enskilda Banken (SEB.A.SS), Evolution (EVO.SS), Telia Co. (TELIA.SS) posted their most recent earnings.

    • In the UK, Unilever (ULVR.LN) posted Q3 underlying sales growth slightly ahead of expectations and reconfirmed FY outlook. Legal & General Group (LGEN.LN) on track to deliver FY25 group core operating EPS growth at higher end of 6-9% range. InterContinental Hotels Group (IHG.LN), Lloyds Banking Group (LLOY.LN), London Stock Exchange Group (LSEG.LN), Antofagasta (ANTO.LN) and Bloomsbury Publishing (BMY.LN) also updated investors with their latest earnings.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Oil & Gas +2.84%, Basic Resources +1.80%, Financial Svcs +0.95%, Ind Goods & Svcs +0.87%, Persnl & HHold Goods +0.79%, Autos & Parts +0.75%, Media +0.46%

      • Underperformers

        • Travel & Leisure (2.29%), Food & Beverage (0.79%), Health Care (0.43%), Real Estate(0.15%), Telecom +0.07%, Insurance +0.17%, Chemicals +0.20%, Banks +0.21%, Utilities +0.24%, Technology +0.26%, Construct & Mtls +0.29%, Retail +0.33%

    • Macro/Peripheral markets:

      • Geopolitics

        • 19th package of sanctions against Russia: EU targets Russian energy, third-country banks and crypto providers - release

        • Trump's oil sanctions shake India and energy markets - FT

        • Belgium's Bart De Wever resists push to use Russian assets for Ukraine - Politico

      • Central Banks

        • SNB Reckoned Policy Settings Will Stoke Inflation in Due Course - Bloomberg

        • Bank of England to Move Financial Regulator Amid Cash Crunch - Bloomberg

        • Financial stability and growth, speech by Jonathan Hall - BoE

      • EU

        • Greek leader pushes EU on joint defense debt - Politico

        • Belgium demands more 'commitments' from EU on €140bn loan to Kyiv - FT

        • Europe adopts 19th sanctions package against Russia, including LNG import ban - Reuters

        • European Council conclusions on European defence and security - release

      • UK

        • France backing away from pledge to intercept migrant boats, sources tell BBC - BBC

        • UK budget fears clouding L&G shares, says CEO - Reuters

        • Keir Starmer prepares to miss key green target in effort to keep energy bills down - The Guardian

        • Sewage pollution and water outages soar in England despite bill increases - FT

      • France

        • French Greens leader announces 2027 presidential bid - Le monde

        • French October Business Confidence Unexpectedly Ticks Higher - Bloomberg

      • Greece

        • Mitsotakis calls for EU borrowing mechanism to fund defense projects - ekathimerini

    • Company news:

      • Notable Gainers

        • +146.0% ALPRO.FP (Prodware €27.60, +16.50) -- Phast Invest announces its intention to file a public buy-out offer, followed by a squeeze-out for Prodware shares at €28 per share

        • +38.1% VOLCAR.B.SS (Volvo Car SEK30.14, +8.66) -- Q3 earnings

        • +18.8% IMM.LN (ImmuPharma £0.12, +0.02) -- cash runway has recently been extended into H2 of 2026

        • +16.7% GEMD.LN (Gem Diamonds £0.03, -0.00)

        • +16.1% PCELL.SS (PowerCell Sweden SEK35.46, +5.14) -- Q3 earnings

        • +14.6% METSO.FH (Metso Corp. €13.13, +1.75) -- Q3 earnings

        • +14.6% GROW.LN (Molten Ventures £4.37, +0.60) -- tradig update

        • +13.9% KIT.NO (Kitron NOK65.65, +8.55) -- Q3 earnings

        • +13.7% NELLY.SS (Nelly Group SEK106.00, +12.20) -- Q3 earnings

        • +12.6% AOF.GR (ATOSS Software €115.00, +13.40) -- Q3 earnings

        • +11.4% BILI.A.SS (Bilia SEK123.80, +13.10) -- Q3 earnings

        • +10.8% NOKIA.FH (Nokia €5.25, +0.51) -- Q3 earnings

        • +10.4% TIETO.FH (Tietoevry €17.60, +1.71) -- Q3 earnings

        • +9.7% RTO.LN (Rentokil Initial £4.43, +0.40) -- Q3 revenue

        • +9.5% SF.SS (Stillfront Group SEK6.40, +0.55) -- Q3 earnings

        • +9.2% GRNG.SS (Gränges SEK131.10, +11.20) -- Q3 earnings

        • +9.0% TGS.NO (TGS-NOPEC Geophysical Co. NOK90.05, +7.45) -- Q3 earnings

        • +8.9% MVIR.SS (Medivir SEK0.57, +0.05) -- enters exclusive licensing agreement with Biossil, Inc. for remetinostat

        • +8.3% KER.FP (Kering €344.15, +26.40) -- Q3 revenue

        • +8.2% ALIF.B.SS (AddLife SEK204.00, +15.30) -- Q3 earnings

        • +8.2% GMET.LN (Guardian Metal Resources £1.08, +0.08) -- updates on Tempiute tungsten project

        • +8.1% RVRC.SS (RVRC Holding SEK60.50, +4.55) -- Q3 earnings

        • +7.5% BANB1.SW (Bachem Holding CHF58.25, +4.00) -- progress in its plans to expand capacity

        • +7.2% HPHA.GR (Heidelberg Pharma €3.15, +0.21) -- ADC candidate HDP-101 granted fast track designation by FDA for the treatment of multiple myeloma

        • +7.2% TELIA.SS (Telia Co. SEK36.69, +2.51) -- Q3 earnings

        • +6.9% BILL.SS (Billerud SEK90.75, +5.90) -- Q3 earnings

        • +6.8% DSV.DC (DSV A/S DKK1,397.00, +90.50) -- Q3 earnings

        • +6.6% LSEG.LN (London Stock Exchange Group £91.86, +5.76) -- trading update; 11 banks agree to invest in its Post Trade Solutions business, taking a 20% stake

        • +5.4% SCST.SS (Scandi Standard SEK97.10, +4.90) -- Q3 earnings

        • +5.3% BMY.LN (Bloomsbury Publishing £5.32, +0.26) -- H1 earnings

        • +4.6% EGTX.SS (Egetis Therapeutics SEK5.74, +0.25) -- granted rolling NDA review by FDA for Emcitate (tiratricol) based on currently available clinical data

        • +4.2% FNAC.FP (Fnac Darty €30.15, +1.20) -- Q3 revenue

      • Notable Decliners

        • -47.4% ATORX.SS (Alligator Bioscience SEK1.38, -1.28) -- Q3 earnings; rights issue of units of SEK 120M and raises bridge loans

        • -20.1% ORX.SS (Orexo SEK35.00, -7.55) -- Q3 earnings

        • -14.0% FRACTL.SS (Fractal Gaming Group SEK32.80, -5.45)

        • -13.7% STMPA.FP (STMicroelectronics €24.82, -3.49) -- Q3 earnings

        • -13.7% ALTHX.FP (THX Pharma €2.18, -0.35) -- share capital increase with preferential subscription rights of nearly €8M

        • -12.8% DSY.FP (Dassault Systemes €25.66, -3.85) -- Q3 earnings

        • -10.9% ENEA.SS (Enea AB SEK69.90, -8.50) -- Q3 earnings

        • -9.1% TTALO.FH (Terveystalo €9.29, -0.92) -- Q3 earnings

        • -8.8% ELISA.FH (Elisa Oyj €41.26, -3.88) -- Q3 earnings; transformation programme to achieve €40M annual cost savings

        • -8.0% EWRK.SS (Ework Group SEK97.00, -8.50) -- Q3 earnings

        • -7.9% DOM.SS (Dometic Group SEK50.00, -4.35) -- Q3 earnings

        • -7.7% PROT.NO (Protector Forsikring NOK469.00, -38.50)

        • -7.4% RCN.LN (Redcentric £1.27, -0.10) -- to dispose Redcentric Data Centre to Stellanor Datacenters Group for up to £127M in cash

        • -7.3% B3.SS (B3 Consulting Group SEK44.00, -3.50) -- Q3 earnings

        • -7.1% PRFO.SS (Profoto Holding SEK11.40, -0.85) -- Q3 earnings

        • -7.1% AXFO.SS (Axfood SEK273.10, -20.40) -- Q3 earnings

        • -7.1% EVO.SS (Evolution SEK659.00, -51.80) -- Q3 earnings

        • -6.9% SW.FP (Sodexo €50.70, -3.90) -- FY earnings

        • -6.7% BONEX.SS (BONESUPPORT HOLDING SEK242.00, -17.20) -- Q3 earnings

        • -6.6% COOR.SS (Coor Service Management Holding SEK47.76, -3.33) -- Q3 earnings

        • -6.4% IPS.FP (Ipsos €35.20, -2.32) -- Q3 revenue

        • -5.5% BACTI.B.SS (Bactiguard Holding SEK14.95, -0.90) -- Q3 earnings

        • -4.8% BKT.SM (Bankinter €12.71, -0.64) -- Q3 earnings

        • -4.8% SOF.B.SS (Softronic SEK22.40, -1.15) -- Q3 earnings

        • -3.8% CA.FP (Carrefour €12.88, -0.51) -- Q3 sales

        • -3.2% ROG.SW (Roche Holding CHF272.10, -8.90) -- Q3 sales

        • -2.8% SAVE.LN (Savannah Energy £0.07, -0.00) -- H1 earnings; operational and financial update, proposed fundraising, warrant purchase and cancellation and conditional share buyback arrangement

        • -2.6% RSW.LN (Renishaw £35.50, -0.95) -- Q1 revenue

        • -2.6% WIHL.SS (Wihlborgs Fastigheter SEK94.60, -2.60) -- Q3 earnings

    • EU companies reporting tomorrow:

      • Benelux: Signify (LIGHT.NA), Cofinimmo (COFB.BB)

      • DACHs: Porsche (P911.GR), Schindler Holding (SCHP.SW), BB Biotech (BION.SW), HBM Healthcare Investments (HBMN.SW)

      • Finland: Kemira (KEMIRA.FH), Hiab (HIAB.FH), Scanfil (SCANFL.FH), Lindex Group (LINDEX.FH), Alandsbanken (ALBBV.FH), Apetit (APETIT.FH), Consti (CONSTI.FH), Modulight (MODU.FH)

      • France: Sanofi (SAN.FP)

      • Norway: Gjensidige Forsikring (GJF.NO), Norsk Hydro (NHY.NO), Bonheur (BONHR.NO), MediStim (MEDI.NO), Komplett (KOMPL.NO), Zalaris (ZAL.NO), Norske Skog (NSKOG.NO), Magnora (MGN.NO),

      • Sweden: Hexagon (HEXA.B.SS), Saab (SAAB.B.SS), Lifco (LIFCO.B.SS), Svenska Cellulosa (SCA.B.SS), Trelleborg (TREL.B.SS), Beijer Ref (BEIJ.B.SS), Sagax (SAGA.B.SS), Lagercrantz Group (LAGR.B.SS), Catena (CATE.SS), HEXPOL (HPOL.B.SS), Munters Group (MTRS.SS), Peab (PEAB.B.SS), Bravida Holding (BRAV.SS), Betsson (BETSB.SS), Bufab (BUFAB.SS), AFRY (AFRY.SS), Lindab International (LIAB.SS), Addnode Group (ANOD.B.SS), Beijer Alma (BEIA.B.SS), Attendo (ATT.SS), NCAB Group (NCAB.SS), Hoist Finance (HOFI.SS), MedCap (MCAP.SS), Volati (VOLO.SS), Momentum Group (MMGR.B.SS), Instalco (INSTAL.SS), Sdiptech (SDIP.B.SS), Alligo (ALLIGO.B.SS), Lightshop (BHG.SS), Duni (DUNI.SS), Hexatronic Group (HTRO.SS), Humble Group (HUMBLE.SS), Byggmax Group (BMAX.SS), Bonava (BONAV.B.SS), Knowit (KNOW.SS), Idun Industrier (IDUN.B.SS), CTT Systems (CTT.SS), Proact IT Group (PACT.SS), Humana (HUM.SS), Cint Group (CINT.SS), FormPipe Software (FPIP.SS), Sedana Medical (SEDANA.SS), Prevas (PREV.B.SS), Tobii (TOBII.SS), Xbrane Biopharma (XBRANE.SS), Nilörngruppen (NIL.B.SS), Sleep Cycle (SLEEP.SS), Alcadon Group (ALCA.SS), Netel Holding (NETEL.SS), Boule Diagnostics (BOUL.SS), Bambuser (BUSER.SS)

      • Southern Europe: Eni (ENI.IM)

      • UK: NatWest Group (NWG.LN)

  • Data:

    • Economics:

      • Norway Sep Unemployment Rate 4.8% vs consensus 4.7% and prior 4.9%

      • France Oct Business Survey 101 vs consensus 96 and prior revised 97 from 96

    • Markets:

      • WTI Crude (Dec 25): +$2.79 or +4.77% to $61.29

      • €-$ (0.0001) or (0.01%) to 1.1609

      • £-$ (0.0040) or (0.30%) to 1.3316

      • €-£ +0.0026 to 0.8718

      • S&P 500 +0.29%

        • Performance year-to-date

        • FTSE 100: +17.25%

        • DAX: +21.57%

        • CAC: +11.54%

        • MIB: +23.97%

        • Stoxx 600: +13.19%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE